StreetAlpha.app
Home › Stocks › PAHC

Phibro Animal Health Corp (PAHC)

Healthcare
$33.29
▼ −2.32%
LAST CLOSE · NOV 20

Phibro Animal Health makes animal health medicines, vaccines and mineral nutrition products for livestock producers. It last closed at $33.29 on Nov 20, down 2.32% on the day. The next earnings report for PAHC is expected around Wed, Feb 3, 2027, after the close. For the quarter ended Sep 2026, PAHC reported EPS of $0.72 on revenue of $386.8M, with revenue up 6.3% from a year ago. Over its last 8 reports the stock moved an average of 13.5% the session after earnings. Over the last 12 months PAHC insiders bought $318K of stock on the open market and sold $24.1M, according to SEC Form 4 filings.

AI Auto Pilots
Is PAHC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PAHC.

Key Stats

Last 12 months
Results
Revenue
$1.5B
+10.1% vs a year ago
Net income
$102.7M
+51.5% vs a year ago
EPS (diluted)
$2.50
+49.7% vs a year ago
Free cash flow
$21.7M
1.4% margin
Balance sheet
Cash & equivalents
$75.5M
At Sep 30
Debt
$610.9M
At Sep 30
Shareholder equity
$417.7M
Fiscal year endsJune
ExchangeNasdaq
Financials history
FY2022: $942.3M$942.3MFY2022FY2023: $977.9M$977.9MFY2023FY2024: $1.0B$1.0BFY2024FY2025: $1.3B$1.3BFY2025FY2026: $1.5B$1.5BFY2026

From PAHC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 3
Estimated date · After the close
Reported EPS
$0.72
Quarter ended Sep 2026
Year ago EPS
$0.65
+10.8% on a GAAP basis
Revenue
$386.8M
+6.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.08Dec '24Mar 2025: $0.51Mar '25Jun 2025: $0.43Jun '25Sep 2025: $0.65Sep '25Dec 2025: $0.67Dec '25Mar 2026: $0.59Mar '26Jun 2026: $0.53Jun '26Sep 2026: $0.72Sep '26Latest $0.72
Revenue by quarter
Dec 2024: $309.3MDec '24Mar 2025: $347.8MMar '25Jun 2025: $378.7MJun '25Sep 2025: $363.9MSep '25Dec 2025: $373.9MDec '25Mar 2026: $383.5MMar '26Jun 2026: $396.7MJun '26Sep 2026: $386.8MSep '26Latest $386.8M
How PAHC moved after its last 8 reports
Average move the session after a report ±13.5%
Nov 4, 2026After the close−10.2%
Aug 26, 2026After the close+0.7%
May 6, 2026After the close−26.2%
Feb 4, 2026After the close+21.9%
Nov 5, 2025After the close+4.6%
Aug 27, 2025After the close+19.4%
May 7, 2025After the close+14.8%
Feb 5, 2025After the close+9.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on PAHCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on PAHC
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PAHC

Technical Analysis

PAHC · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 9% below its 20 day and 10% below its 50 day average. It is 23% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38), near oversold. The nearest support is the swing low (Sep 24) at $33.05, and the nearest resistance the Pivot at $33.70.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 4.6%/day
Key levels
$60.0852 week high+80.5%
$40.84200 day average+22.7%
$36.5150 day average+9.7%
$36.3020 day average+9.0%
$35.88100 day average+7.8%
$34.13Pivot R1+2.5%
$33.99Swing high (Jun 5)+2.1%
$33.70Pivot+1.2%
$33.29Last close
$33.05Swing low (Sep 24)−0.7%
$32.86Pivot S1−1.3%
$28.2552 week low−15.1%
Indicators
RSI (14)37.58Weak, oversold below 30Neutral
MACD-0.86Below its signal lineBearish
Stochastic18.6Near the bottom of its rangeOversold
ADX (14)22.2Weak trend
Williams %R-94.4Oversold below −80, overbought above −20Oversold
CCI (20)-98.8Oversold below −100, overbought above 100Neutral
Rate of change+1.0%Change over 10 sessionsBullish
ATR (14)$1.54Typical daily range, 4.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PAHC

What happened before

See how PAHC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PAHC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PAHC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PAHCHow many large options trades hit PAHC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

PAHC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲139 buying vs 83 selling
  • ▲Shares held by funds +4.3%
  • ▲Funds holding +26
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding236210+12.4%
In funds' top 1000–
Held by funds–––
New / increased45 / 9433 / 80+23.0%
Reduced / sold out62 / 2178 / 80−47.5%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PAHC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

PAHC Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$318K1 buy · 1 insider
Sold$24.1M26 sales · 2 insiders
100% of the selling was under pre-arranged trading plans.
2025-12 sold $1.0M2026-01 sold $2.3M2026-02 sold $12.2M2026-03 sold $3.4M2026-04 sold $3.5M2026-05 bought $318K2026-05 sold $1.0MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
May 29E Thomas CorcoranDirectorBuy10,000$31.77$318K
May 7Jack BendheimPresident and CEOSale plan18,608$54.61$1.0M
Apr 30Jack BendheimPresident and CEOSale plan21,120$53.86$1.1M
Apr 23Jack BendheimPresident and CEOSale plan21,120$54.79$1.2M
Apr 16Jack BendheimPresident and CEOSale plan21,120$56.89$1.2M
Mar 31Jack BendheimPresident and CEOSale plan14,080$53.75$757K
Every insider buy and sale for PAHC over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See PAHC insider trades →

From SEC Form 4 filings by PAHC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PAHC is in one of them and how their past PAHC trades turned out.

PAHC in the AI portfolios
Loading…

PAHC News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PAHC in an article yet. Here's the latest on the wider market.

PAHC in the news

About Phibro Animal Health

Phibro Animal Health is an animal health and mineral nutrition company based in Teaneck, New Jersey. It makes medicines and vaccines for farm animals such as poultry, cattle, swine and aquaculture species, along with mineral products that support animal diets. Its customers include integrated poultry, cattle and swine producers, animal feed manufacturers, distributors and veterinarians. The company also makes specialty ingredients for personal care and industrial chemical uses.

Headquarters
Teaneck, NJ